Adaptive SABR Boost Shows Promise in Advanced NSCLC : vimars

Radiation dose-escalation combined with stereotactic ablative radiotherapy may improve locoregional control in patients with NSCLC.

Related Keywords

California , United States , Los Angeles , Trudyc Wu , University Of California , Lung Cancer , Ung Carcinoma , Ancer Of The Lung , Non Small Cell Lung Cancer , Nsclc , Radiation Dose , Radiation Therapy , Radiotherapy , Radiation Oncology , Biologic Therapy , Iologics , Immunotherapy , Small Cell Lung Cancer , At Cell Lung Cancer , Clc , A Scan Biometry , A Scan Ultrasound Biometry , Ea Scan , Cancer , Alignant Neoplasia , Arcinoma , Alignant Neoplasm , Lung ,